Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
Comparing and combining in silico outcomes and in vitro mechanism-based assays to predict genotoxicityMarch 2020pdf fileDerek NexusVitic Nexus
Updated Dermal Sensitisation Thresholds derived using an in silico expert system and an expanded Local Lymph Node Assay datasetMarch 2020pdf fileDerek NexusVitic Nexus
Utilising Adverse Outcome Pathways as a Framework to Organise Evidence and Support Carcinogenicity Risk AssessmentMarch 2020pdf fileKaptis
Are All Nitrosamines Concerning?March 2020pdf fileVitic Nexus
Consortium-led federated QSAR models for secondary pharmacology - preparing the dataMarch 2020pdf fileEffiris
Validating proposed improvements to phototoxicity expert alerts against proprietary dataMarch 2020pdf fileDerek Nexus
Generation of novel in chemico in vitro skin sensitisation data to evaluate the human relevance of defined approachesMarch 2020pdf fileDerek Nexus
From Private Data to Shared KnowledgeMarch 2020pdf fileEffiris
Predicting the safety of medicines in pregnancy: A workshop reportMarch 2020Kaptis
ICH M7 Workshop - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah NexusZenethVitic NexusSetariaMirabilis
Predictions, Data and ICH M7 - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah NexusVitic NexusSetaria
Lhasa and the ICH M7 Guideline - 2020 ICH M7 India RoadshowMarch 2020pdf fileDerek NexusSarah NexusVitic NexusSetariaMirabilis
GSK MI risk assessment process Camicinal at al - 2020 ICH M7 India RoadshowMarch 2020pdf fileDerek NexusSarah NexusVitic Nexus
Hazard Assessment of Potentially Mutagenic Impurities - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah Nexus
ICH M7 - Regulatory Updates and Industry Practices - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah Nexus
Lhasa Expert Review Developments - 2020 ICH M7 India RoadshowsMarch 2020pdf fileDerek NexusSarah NexusVitic Nexus
Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy options - RecordingJanuary 2020Mirabilis
Quantitative Analysis of In Vivo Dose-Response Data for Risk Assessment and Regulatory Decision Making - RecordingJanuary 2020
Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy optionsJanuary 2020pdf fileMirabilis
Quantitative Analysis of In Vivo Dose-Response Data for Risk Assessment and Regulatory Decision Making - A Case Study of AlkylnitrosaminesJanuary 2020pdf file
Future Developments AOP Networks And Predicting Secondary PharmacologyJanuary 2020pdf fileEffirisKaptis
Carcinogenicity Adverse Outcome PathwaysJanuary 2020pdf fileDerek NexusKaptisVitic Nexus
Beyond Mutagenicity: Supporting Toxicity Assessments For Other EndpointsJanuary 2020pdf fileDerek Nexus
Setaria 3.1.1 Installation GuideJanuary 2020pdf fileSetaria
The use of in-silico tools to assist in the practical management of impurities under ICH M7.December 2019

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.